VACCINATION SITE PRURITUS

This adverse event was reported 42 times

These drugs are most commonly taken by patients reporting VACCINATION SITE PRURITUS:

# Drug Count
0 ADALIMUMAB 16
1 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 7
2 ALBUTEROL SULFATE 5
3 AMITRIPTYLINE HYDROCHLORIDE 5
4 MESALAMINE 4
5 PRAMIPEXOLE 4
6 VEDOLIZUMAB 4
7 ACETAMINOPHEN 3
8 AMLODIPINE 3
9 ASPIRIN 3
See all common drugs associated with VACCINATION SITE PRURITUS

VACCINATION SITE PRURITUS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 7 0.0032
1 AMITRIPTYLINE HYDROCHLORIDE 5 0.0005
2 GRANULOCYTE COLONY STIMULATING FACTOR 1 0.0004
3 NITRIC OXIDE 1 0.0004
4 IMIQUIMOD 1 0.0004
5 ACARBOSE 1 0.0003
6 BAMLANIVIMAB 1 0.0003
7 PIMECROLIMUS 1 0.0003
8 HUMAN IMMUNOGLOBULIN G 2 0.0002
9 VITAMIN A 1 0.0002
See all drugs enriched for association with VACCINATION SITE PRURITUS

VACCINATION SITE PRURITUS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 7 0.0032
1 alpha-Glucosidase Inhibitor [EPC] 1 0.0003
2 Human Immunoglobulin G [EPC] 2 0.0002
3 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 3 0.0001
4 Aromatic Amino Acid [EPC] 3 0.0001
5 Guanylate Cyclase-C Agonist [EPC] 1 0.0000
6 Aminosalicylate [EPC] 4 0.0000
7 alpha-Adrenergic Agonist [EPC] 1 0.0000
8 Expectorant [EPC] 3 0.0000
9 Vitamin A [EPC] 1 0.0000
See all drug classes enriched for association with VACCINATION SITE PRURITUS